» Authors » Jacob Peer

Jacob Peer

Explore the profile of Jacob Peer including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 122
Citations 1602
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hershcovici R, Frenkel S, Goldstein G, Peer J, Eiger-Moscovich M
Semin Ophthalmol . 2025 Jan; 1-6. PMID: 39773294
Purpose: Trilateral retinoblastoma (TRB), intracranial neoplasm in heritable retinoblastoma patients, is a very rare fatal disease. Many ocular oncology centers conduct routine screening of retinoblastoma patients by brain imaging. Nevertheless,...
2.
Kaliki S, Vempuluru V, Ahmad A, Berry J, Diaz-Coronado R, Eiger-Moscovich M, et al.
Clin Exp Ophthalmol . 2024 Dec; PMID: 39731391
Background: To evaluate the clinical presentation, pathological features and outcomes of retinoblastoma based on the race of origin in a global cohort of patients. Methods: Retrospective collaborative study of 1426...
3.
Ginosar Y, Sandman O, Tevet A, Boret M, Greenberger R, Boim Z, et al.
Int J Obstet Anesth . 2024 Dec; 61:104307. PMID: 39700744
Background: Observational studies should not be used to infer causation as they are prone to confounding factors, selection bias, and reverse causality. Many observational studies of labor analgesia treated epidurals...
4.
Negretti G, Ushakova T, Yuri S, Vladimir P, Berry J, Pike S, et al.
Retina . 2024 Dec; 45(3):565-573. PMID: 39622251
Purpose: To assess histopathology and outcomes after primary enucleation of eyes with retinoblastoma presenting with neovascular glaucoma (NVG). Methods: This was an international multicenter case series study across five continents....
5.
Arazi M, Baum A, Casavilca-Zambrano S, Alarcon-Leon S, Diaz-Coronado R, Ahmad A, et al.
Am J Ophthalmol . 2024 Sep; 268:399-408. PMID: 39332513
Purpose: To compare the clinical outcomes of children with unilateral retinoblastoma (Rb) and high-risk histopathology features (HRHF) following upfront enucleation with/without adjuvant chemotherapy, and investigate cases locally considered non-HRHF but...
6.
Kaliki S, Vempuluru V, Bakal K, Dorji S, Tanna V, Shields C, et al.
Retina . 2024 Aug; 44(12):2105-2115. PMID: 39151183
Purpose: To evaluate high-risk histopathological features following primary enucleation of eyes with retinoblastoma and assess the patient outcomes across continents. Methods: A retrospective study of 1,426 primarily enucleated retinoblastoma eyes...
7.
Frenkel S, Peer J, Deckel Y, Gur Z, Kehat Ofir S, Eiger-Moscovich M
Can J Ophthalmol . 2024 Aug; PMID: 39106964
Objective: Treatment of palpebral conjunctival lesions is problematic due to late diagnosis, difficult surgical approach, and the need to preserve eyelid integrity. We describe our treatment experience using plaque brachytherapy...
8.
Habot-Wilner Z, Peer J, Frenkel S
Clin Exp Ophthalmol . 2023 Feb; 51(2):107-109. PMID: 36789671
No abstract available.
9.
Barak V, Kalickman I, Peer J
Anticancer Res . 2022 Feb; 42(3):1447-1453. PMID: 35220238
Background/aim: Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. High serum levels of soluble IL-2 receptor (sIL-2R) have been reported in acute inflammations and metastatic cancers....
10.
Dalvin L, Pulido J, Shields C, Marchese A, Miserocchi E, Frenkel S, et al.
Eye (Lond) . 2022 Jan; 37(1):54-61. PMID: 34999721
Objectives: To investigate the risk of developing central nervous system (CNS) lymphoma in patients with vitreoretinal lymphoma (VRL) presenting with unilateral versus (vs.) bilateral ocular involvement. Methods: Retrospective, multicentre cohort...